Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
Mira JA, López-Cortés LF, Barreiro P, Tural C, Torres-Tortosa M, de Los Santos Gil I, Martín-Rico P, Ríos-Villegas MJ, Hernández-Burruezo JJ, Merino D, López-Ruz MA, Rivero A, Muñoz L, González-Serrano M, Collado A, Macías J, Viciana P, Soriano V, Pineda JA. Mira JA, et al. Among authors: hernandez burruezo jj. J Antimicrob Chemother. 2008 Dec;62(6):1365-73. doi: 10.1093/jac/dkn420. Epub 2008 Oct 13. J Antimicrob Chemother. 2008. PMID: 18854330 Clinical Trial.
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.
Lozano F, Torre-Cisneros J, Bascuñana A, Polo J, Viciana P, García-Ordóñez MA, Hernández-Quero J, Márquez M, Vergara A, Díez F, Pujol E, Torres-Tortosa M, Pasquau J, Hernández-Burruezo JJ, Suárez I. Lozano F, et al. Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):705-11. doi: 10.1007/BF01691956. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8922569
[Urinary tract infections].
Hernández-Burruezo JJ, Omar Mohamed-Balghata M, Aliaga Martínez L; Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Hernández-Burruezo JJ, et al. Med Clin (Barc). 2007 Nov 17;129(18):707-15. doi: 10.1157/13112512. Med Clin (Barc). 2007. PMID: 18021614 Review. Spanish. No abstract available.
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Berenguer J, González J, Ribera E, Domingo P, Santos J, Miralles P, Angels Ribas M, Asensi V, Gimeno JL, Pérez-Molina JA, Terrón JA, Santamaría JM, Pedrol E; GESIDA 3903 Team. Berenguer J, et al. Clin Infect Dis. 2008 Oct 15;47(8):1083-92. doi: 10.1086/592114. Clin Infect Dis. 2008. PMID: 18781872 Clinical Trial.
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Núñez M, Miralles C, Berdún MA, Losada E, Aguirrebengoa K, Ocampo A, Arazo P, Cervantes M, de Los Santos I, San Joaquín I, Echeverría S, Galindo MJ, Asensi V, Barreiro P, Sola J, Hernandez-Burruezo JJ, Guardiola JM, Romero M, García-Samaniego J, Soriano V; PRESCO Study Group. Núñez M, et al. Among authors: hernandez burruezo jj. AIDS Res Hum Retroviruses. 2007 Aug;23(8):972-82. doi: 10.1089/aid.2007.0011. AIDS Res Hum Retroviruses. 2007. PMID: 17725413 Clinical Trial.
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
Soriano V, Miralles C, Berdún MA, Losada E, Aguirrebengoa K, Ocampo A, Arazo P, Cervantes M, de los Santos I, San Joaquín I, Echeverria S, Galindo MJ, Asensi V, Barreiro P, Sola J, Hernandez-Burruezo JJ, Guardiola J, Blanco F, Martin-Carbonero L, García-Samaniego J, Nuñez M; PRESCO Study Group. Soriano V, et al. Among authors: hernandez burruezo jj. Antivir Ther. 2007;12(4):469-76. Antivir Ther. 2007. PMID: 17668555 Clinical Trial.
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
Núñez M, Mariño A, Miralles C, Berdún MA, Sola J, Hernandez-Burruezo JJ, Galindo MJ, Barreiro P, Martin-Carbonero L, Soriano V. Núñez M, et al. Among authors: hernandez burruezo jj. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):439-44. doi: 10.1097/QAI.0b013e318061b5d9. J Acquir Immune Defic Syndr. 2007. PMID: 17468669 Clinical Trial.
[Syncope as first manifestation of primary amyloidosis].
Gea I, Duro G, Ruiz-Avila I, Hernández Burruezo JJ. Gea I, et al. Among authors: hernandez burruezo jj. An Med Interna. 2000 May;17(5):275-6. An Med Interna. 2000. PMID: 10859833 Spanish. No abstract available.
[Weight loss, fever, and pancytopenia in a patient with skin lesions].
Marín Rubio A, Omar Mohamed M, Duro Ruiz G, Rómero Ferreira MD, García Jiménez R, Hernández Burruezo JJ. Marín Rubio A, et al. Among authors: hernandez burruezo jj. Rev Clin Esp. 1999 Dec;199(12):853-4. Rev Clin Esp. 1999. PMID: 10687423 Spanish. No abstract available.
[Pustulous psoriasis resistant to conventional treatment].
Martín-Rubio A, Hernández-Burruezo JJ, Omar M, García C, Duro G, Romero MD. Martín-Rubio A, et al. Among authors: hernandez burruezo jj. Enferm Infecc Microbiol Clin. 1999 Oct;17(8):413-4. Enferm Infecc Microbiol Clin. 1999. PMID: 10563092 Spanish. No abstract available.
17 results